What is Clinical Research Optimized™?
Biorasi is not just a contract research organization. We are a new kind of CRO, dedicated to delivering Clinical Research Optimized™ for our sponsors. We believe that the contract research organization industry is failing sponsors, and we strive achieve the ideal balance of cost, time and risk for our sponsors in every trial . Through innovative processes and technologies, dedication to sponsors, and a culture of ownership, our team will deliver your trial on time and on budget, every time.
KEEP YOUR CLINICAL TRIALS ON TARGET
Biorasi is recognized as a leading expert in delivering success where other CROs fail.
We are a trial rescue expert, recognized for our ability to complete trials that much larger CROs falter on. In our 15 years of experience, we’ve been able to rescue clinical trials from some of the leading names in pharma, lead by some of the most prominent contract research organizations in the world. Our rescue expertise doesn’t just save our sponsors time and money – it saves entire drug development programs.
"One of the rarest events, where we had to communicate [to Biorasi] to stop the screening rather than boost it."
VP of Global Clinical Development, Top Specialty PharmaLatest News
Why Aren’t There Any FDA-Approved Drugs to Treat NASH?
The liver does many important things in the body, such as filtering of the blood and metabolizing all compounds, including food and drugs, that enter the body. In that vein, liver disease can be absolutely devastating. Non-alcoholic fatty liver disease (NAFLD)...
read more
10 Lessons On Success in Asia-PAC Trials from DIA 2018
Earlier this year, a few of us attended DIA 2018 to represent Biorasi. While there, we were fortunate enough to be able to give a talk about some of our experiences entitled “Balancing Unity and Individuality: Leadership Skills for Managing Culturally Divergent...
read more
You’re Holding Your Eye Drops Wrong – What Makes Ophthalmology Trials so Challenging?
Last week, one of our resident experts in ophthalmology, Ignacio Handal, gave a training for some of our current studies with a focus on which pitfalls to avoid specifically in ophthalmology trials. He dished out many fun facts and eye-opening insights. Compliance is...
read more
A More Complete Scope for Advances in Women’s Health
When people think about women’s health, especially during the month of October, they may think only of breast cancer or reproductive disorders. The truth, though, is that women’s health encompasses so much more. The field of medicine pertaining to women’s health is...
read more
The Politics of Investigator-Initiated Trials
Many clinical trials are initiated by a pharmaceutical company in order to generate data to submit to the FDA for drug approval. Investigator-initiated trials (IITs), on the other hand, are conceived by a clinician and not by the company that plans to sell the drug or...
read more
Six Things We Can Do Now to Advance Clinical Research in CKD
“What we need to do is to keep working on getting biomarkers more defined to be able to differentiate between the different etiologies. This is going to be the path forward.” Chronic kidney disease (CKD) is actually 20 times more prevalent and 100 times more lethal...
read more